MDA National Ltd v Medical Defence Australia Ltd

Link copied
Case Copied 50 min read

FEDERAL COURT OF AUSTRALIA

MDA National Limited v Medical Defence Australia Limited [2014] FCA 954

Citation: MDA National Limited v Medical Defence Australia Limited [2014] FCA 954
Parties: MDA NATIONAL LIMITED ABN 62 055 801 771 and MEDICAL DEFENCE ASSOCIATION OF SOUTH AUSTRALIA LIMITED ABN 41 007 547 588 v MEDICAL DEFENCE AUSTRALIA LIMITED ACN 600 579 735
File number(s): NSD 805 of 2014
Judge(s): YATES J
Date of judgment: 20 August 2014
Catchwords:

CORPORATIONS  - schemes of arrangement – applications for orders that the companies convene meetings of members

PRACTICE AND PROCEDURE – whether proceedings correctly constituted – whether each plaintiff can be separately represented – whether solicitors for the first plaintiff can also act for the defendant – approval of delivery of scheme documents to members through electronic links in emails

Legislation: Corporations Act 2001 (Cth) ss 249J 411, 412
Insurance Act 1973 (Cth)
Federal Court Rules 2011 (Cth) O 45
Federal Court (Corporations) Rules 2000 (Cth)
Federal Court of Australia Act 1976 (Cth)
Medical Indemnity (Prudential Supervision and Product Standards) Act 2003 (Cth) ss 3, 10
Uniform Civil Procedures Rules 2005 (NSW)
Cases cited:

Alinta Ltd (No 2) [2007] FCA 1378
Carnie v Esanda Finance Corporation Ltd (1996) 38 NSWLR 465
Re Consolidated Media Holdings Ltd [2012] FCA 1186
Centrebet International Limited, in the matter of Centrebet International Limited [2011] FCA 870
Re David Jones Ltd [2014] FCA 530
Elphick v Westfield Shopping Centre Management Co Pty Ltd (2011) 216 IR 41
Equatorial Mining Pty Limited v Antofagasta Investment Company Limited [2013] FCA 1452
Re Foundation Healthcare Ltd (2002) 42 ACSR 252
FT Eastment & Sons Pty Ltd v Metal Roof Decking Supplies Pty Ltd (1977) 3 ACLR 69
Goold & Porter Pty Limited v Housing Commission [1974] VR 102
Re Hills Motorway Limited (No 2) 43 ACSR 101
Johnson Tiles Pty Ltd v Esso Australia Ltd (1999) ATPR 41-679
Kirby v Centro Properties Ltd (2008) 253 ALR 65
Lewis v Daily Telegraph Ltd (No 2) [1964] 2 QB 601
Marengo Mining Ltd (No 2) [2012] FCA 1498
Re MIA Group Ltd (2004) 50 ACSR 29
Re Nine Entertainment Group Limited (No 1) (2012) 211 FCR 439
Re Permanent Trustee Co Ltd (2002) 43 ACSR 601
In the matter of Professional Golfers Association of Australia Limited [2007] FCA 1571
Royal Victorian Institute for the Blind Limited v RBS.RVIB.VAF Ltd (2004) 206 ALR 581
SCI Operations Pty Ltd v Australian Paper Manufacturers Ltd (1983) 51 ALR 365
Re Sino Gold Mining Ltd (2009) 74 ACSR 647
In the matter of Stork ICM Australia Pty Ltd; Stork ICM Australia Pty Ltd v Stork Food Systems Australasia Pty Ltd [2006] FCA 1849
Sovereign Life Assurance Co v Dodd [1892] 2 QB 573
In the application of United Medical Protection Limited [2007] FCA 631
Wedderburn v Wedderburn (1853) 17 Beav 158

Date of hearing: 20 August 2014
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 109
Counsel for the First Plaintiff: Mr Dick SC with Mr Dawson
Solicitor…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read MDA National Ltd v Medical Defence Australia Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2014] FCA 954
Decision Date

CaseChat Overview and Summary

The case of MDA National Ltd v Medical Defence Australia Ltd involves a scheme of arrangement application by two companies, MDA National Ltd and Medical Defence Australia Ltd, seeking orders to convene meetings of their respective members. The Federal Court of Australia was tasked with determining several legal issues, including whether the proceedings were correctly constituted, if each plaintiff could be separately represented, and if the solicitors for the first plaintiff could also act for the defendant. Furthermore, the Court had to decide on the approval of delivering scheme documents to members through electronic links in emails.

The court examined the nature of the proceeding, which was essentially non-adversarial and consensual in nature. The Court held that the proceeding could be properly constituted as a single proceeding involving separate plaintiffs as it reflected the realities of the merger the parties sought to achieve. The Court also found that it would be appropriate for the plaintiffs to be separately represented, including by separate counsel, and that the first plaintiff's solicitors could act for the defendant as well.

In light of the Court's reasoning, the final orders included convening meetings of members for both MDA National Ltd and Medical Defence Australia Ltd to consider and agree to the respective schemes of arrangement. The Court also approved the delivery of scheme documents to members through electronic links in emails and exempted the plaintiffs from certain procedural requirements under the Federal Court (Corporations) Rules 2000.

The proceeding was stood over to 23 October 2014, before Justice Yates, for the hearing of an application to approve the MDA National Ltd and Medical Defence Australia Ltd schemes. The Court granted liberty to restore on two days' notice and ordered the entry of the orders forthwith.

Orders

Orders of the court

MDAN SCHEME

1. Order pursuant to section 411(1) of the Corporations Act 2001 (Corporations Act) that:

(a) the first plaintiff convene a meeting of its members for the purpose of considering and, if thought fit, agreeing (with or without modification) to a scheme of arrangement proposed between the first plaintiff and its members (the MDAN Scheme Meeting), being the scheme of arrangement substantially in the form at Annexure A (the MDAN Scheme) of the scheme booklet which is Exhibit 1 in the proceeding (the Scheme Booklet).

(b) the MDAN Scheme Meeting be held at 1.30pm (Australian Eastern Daylight Time) on 11 October 2014 at Level 3, 88 Collins Street, West Perth, Western Australia.

(c) the chairperson of the MDAN Scheme Meeting be Julian Lockhart Rait and in his absence Dr Beres Carmel Anne Wenck (the MDAN chairperson).

(d) the MDAN chairperson has the power to adjourn the MDAN Scheme Meeting in his or her absolute discretion.

(e) all voting at the MDAN Scheme Meeting (other than procedural matters) be by poll as declared by the MDAN chairperson.

(f) MDAN members may lodge a proxy form in accordance with the instructions given in the Scheme Booklet at Annexure ‘F’, with any such proxies to be delivered to the Deputy Company Secretary at least 48 hours before the specified time for holding the MDAN Scheme Meeting.

(g) the explanatory statement in the form of the Scheme Booklet be approved for distribution to MDAN members.

2. Direct pursuant to section 1319 of the Corporations Act that:

(a) the Scheme Booklet be dispatched to those MDAN members for whom MDAN maintains a current electronic address by sending an email, including a URL link to www.mdanational.com.au, substantially in the form of Annexure ‘A’ to these Orders to each such member on or before 18 September 2014

(b) the Scheme Booklet be dispatched by prepaid ordinary post (or in the case of overseas members, by airmail) together with a cover sheet substantially in the form of Annexure ‘B’ to these Orders to the address of those MDAN members for whom MDAN does not maintain a current email address.

(c) it shall not be necessary for the Scheme Booklet to be dispatched by prepaid ordinary post (or in the case of overseas members, by airmail) to the registered address of those MDAN members to whom the Scheme Booklet has been dispatched as contemplated in order 2(a).

MDASA SCHEME

3. Pursuant to section 411(1) of the Corporations Act:

(a) the second plaintiff convene a meeting of its members for the purpose of considering and, if thought fit, agreeing with or without modification to a scheme of arrangement proposed between the second plaintiff and its members (the MDASA Scheme Meeting), being the scheme substantially in the form at Annexure A of the Scheme Booklet (the MDASA Scheme).

(b) the MDASA Scheme Meeting be held at 10:30 am (Australian Eastern Daylight Time) (or as soon thereafter as the General Meeting has concluded or adjourned), on 11 October 2014 at Level 14, 70 Franklin Street, Adelaide, South Australia.

(c) the chairperson of the MDASA Scheme Meeting be Dr John Augustine O’Loughlin and in his absence Martin Frank Altmann (the MDASA chairperson).

(d) the MDASA chairperson has the power to adjourn the MDASA Scheme Meeting in his absolute discretion.

(e) all voting at the MDASA Scheme Meeting (other than procedural matters) be by poll as declared by the MDASA chairperson.

(f) MDASA members may lodge a proxy form in accordance with the instructions given in the Scheme Booklet at Annexure ‘G’, with any such proxies to be delivered to the authorised officer at least 48 hours before the specified time for holding the MDASA Scheme Meeting.

(g) the Scheme Booklet be approved for distribution to MDASA members.

4. Direct pursuant to section 1319 of the Corporations Act that:

(a) the Scheme Booklet be dispatched to those MDASA members who have supplied an electronic address to MDASA for the purpose of MDASA sending notice to the MDASA member of any meeting by sending an email, including a URL link to www.miga.com.au, substantially in the form of Annexure ‘C’ to these Orders to each such member on or before 5.00pm on 18 September 2014

(b) the Scheme Booklet be dispatched by prepaid ordinary post (or in the case of overseas members, by airmail together with a cover sheet substantially in the form of Annexure ‘D’ to these Orders to the address of those MDASA members who have not nominated an electronic address for the purposes of receiving notification of notices of any meeting.

(c) it shall not be necessary for the Scheme Booklet to be dispatched by prepaid ordinary post (or in the case of overseas members, by airmail) to the registered address of those MDASA members to whom the Scheme Booklet has been dispatched as contemplated in order 4(a).

GENERAL

5. Direct pursuant to section 1319 of the Corporations Act that:

(a) the first plaintiff be exempted from compliance with the requirements of rule 2.15 of the Federal Court (Corporations) Rules 2000 (Cth) save that regulation 5.6.13 of the Corporations Regulations 2001 (Cth) shall apply to each of the MDAN Scheme Meeting; and

(b) the second plaintiff be exempted from compliance with the requirements of rule 2.15 of the Federal Court (Corporations) Rules 2000 (Cth) save that regulation 5.6.13 of the Corporations Regulations 2001 (Cth) shall apply to each of the MDASA Scheme Meeting.

6. Order that:

(a) the first plaintiff publish in The Australian newspaper a notice substantially in the form of Annexure ‘E’.

(b) the second plaintiff publish in The Australian newspaper a notice substantially in the form of Annexure ‘F’.

7. Order that evidence in this proceeding be evidence in the matter of MDA National Insurance Pty Limited case number NSD 810/2014 and evidence in matter number NSD 810/2014 be evidence in this proceeding.

8. Order that the proceeding be stood over to 23 October 2014 at 10.15 am, before Justice Yates for the hearing of an application to approve the MDAN Scheme and the MDASA Scheme.

9. Order that there be liberty to restore on 2 days’ notice.

10. Order that these Orders be entered forthwith.

Date that entry is stamped: 20 August 2014

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established

An affidavit has been made by Mr Botha, a director of MDA, in which he deposes that MDA does not wish to be served with court process in relation to the schemes or the amalgamation; that MDA does not wish to appear or be heard in relation to the amalgamation; and that MDA consents to any orders of the Court which are made to effect the amalgamation. MDA does not seek to take, and has not taken, any active role in the proceeding. Consideration In the present case, I can see no difficulty in the proceeding relating to separate schemes involving separate plaintiffs. MDAN and MDASA have come together to bring about a merger of their organisations and insurance businesses in a way they perceive to be in the interests of their respective members. They have chosen to do so under the supervision of the Court utilising the beneficial procedures of Pt 5.1 of the Act. In the present case, there is no apparent reason why there should be separate proceedings for the separate members’ schemes, although it would have been open to MDAN and MDASA to have proceeded in that way. Had they done so, I have no doubt that, as a matter of case management, the two proceedings would have been heard together. The schemes are interdependent. Necessarily, there would have been common evidence. In light of the orders intended to be sought under s 413(1) of the Act, MDA would have been a party to each such proceeding. The proceeding, as presently constituted with the two plaintiffs, simply reflects the realities of the merger they seek to achieve and thus the commercial context in which the proceeding is brought. It also conveniently brings together, for anticipated approval, the various transactions that are sought to be achieved. If possible, the Court’s process should reflect these realities. Efficiency will be promoted by doing so: see s 37M(1) of the Federal Court Act. It seems to me that the real questions are, first, whether it is appropriate for the plaintiffs to be separately represented, including by separate counsel, and secondly, whether the first plaintiff’s solicitors should also act for the defendant. As to the first question, it is significant, in my view, that the proceeding is essentially non-adversarial in nature. All parties are striving to achieve the same end. To that extent, the proceeding is also consensual in nature. The problems associated with separate representation for separate plaintiffs will not arise in the present proceeding as they do in adversarial proceedings. For one thing, MDA does not propose to take any active role in the proceeding. So far as potential objectors to the schemes are concerned, any uncertainty as to the correct address for giving notice can be avoided by the appropriate orders for advertising clearly specifying the address to which notification of objections to the MDAN scheme must be sent, and the address to which notification of objections to the MDASA scheme must be sent. Moreover, although the proceeding has the characteristics I have described, it is nevertheless understandable that the plaintiffs wish to have the benefit of separate advice and representation. The possibility of conflicting interests remains. One obvious example would be where one plaintiff receives a competing proposal from another organisation, which is adverse to the interests of the other plaintiff.